Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome

BACKGROUND AND OBJECTIVE: Intravenous immunoglobulin (IVIg) at a standard dosage is the treatment of choice for Guillain–Barré syndrome. The pharmacokinetics, however, is highly variable between patients, and a rapid clearance of IVIg is associated with poor recovery. We aimed to develop a model to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokkink, Willem Jan R., van Tilburg, Sander J., de Winter, Brenda C. M., Sassen, Sebastiaan D. T., van Doorn, Pieter A., Koch, Birgit C. P., Jacobs, Bart C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439991/
https://www.ncbi.nlm.nih.gov/pubmed/35781631
http://dx.doi.org/10.1007/s40262-022-01136-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439991/
https://www.ncbi.nlm.nih.gov/pubmed/35781631
http://dx.doi.org/10.1007/s40262-022-01136-z

Ejemplares similares